CD19 and Decreased circulating immunoglobulin concentration: For example, patients who receive CD19‐CAR treatment develop a profound immunoglobulin deficiency since normal B cells are also targeted by CD19‐CAR, requiring frequent immunoglobulin infusions 57, 58.